Literature DB >> 25648557

PYK2 sustains endosomal-derived receptor signalling and enhances epithelial-to-mesenchymal transition.

Nandini Verma1, Omer Keinan1, Michael Selitrennik1, Thomas Karn2, Martin Filipits3, Sima Lev1.   

Abstract

Epithelial-to-mesenchymal transition (EMT) is a central developmental process implicated in cancer metastasis. Here we show that the tyrosine kinase PYK2 enhances cell migration and invasion and potentiates EMT in human breast carcinoma. EMT inducer, such as EGF, induces rapid phosphorylation of PYK2 and its translocation to early endosomes where it co-localizes with EGFR and sustains its downstream signals. Furthermore, PYK2 enhances EGF-induced STAT3-phosphorylation, while phospho-STAT3 directly binds to PYK2 promoter and regulates PYK2 transcription. STAT3 and PYK2 also enhance c-Met expression, while c-Met augments their phosphorylation, suggesting a positive feedback loop between PYK2-STAT3-c-Met. We propose that PYK2 sustains endosomal-derived receptor signalling and participates in a positive feedback that links cell surface receptor(s) to transcription factor(s) activation, thereby prolonging signalling duration and potentiating EMT. Given the role of EMT in breast cancer metastasis, we also found a significant correlation between PYK2 expression, tumour grade and lymph node metastasis, thus, demonstrating the clinicopathological implication of our findings.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25648557     DOI: 10.1038/ncomms7064

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  31 in total

Review 1.  The interface between phosphatidylinositol transfer protein function and phosphoinositide signaling in higher eukaryotes.

Authors:  Aby Grabon; Vytas A Bankaitis; Mark I McDermott
Journal:  J Lipid Res       Date:  2018-11-30       Impact factor: 5.922

Review 2.  Focal adhesion kinase signaling in unexpected places.

Authors:  Elizabeth G Kleinschmidt; David D Schlaepfer
Journal:  Curr Opin Cell Biol       Date:  2017-02-16       Impact factor: 8.382

3.  A Dual Role for the Nonreceptor Tyrosine Kinase Pyk2 during the Intracellular Trafficking of Human Papillomavirus 16.

Authors:  Elinor Y Gottschalk; Patricio I Meneses
Journal:  J Virol       Date:  2015-06-24       Impact factor: 5.103

4.  High expression of PYK2 is associated with poor prognosis and cancer progression in early-stage cervical carcinoma.

Authors:  Can Zhang; Xinghua Zhu; Yong Li; Jia Shao; Haibo Xu; Lei Chen; Youli Dan; Hua Jin; Aiqin He
Journal:  Medicine (Baltimore)       Date:  2022-10-14       Impact factor: 1.817

5.  Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.

Authors:  Ni Xie; Yujiang Yao; Lili Wan; Ting Zhu; Litao Liu; Jianhui Yuan
Journal:  Exp Ther Med       Date:  2017-05-17       Impact factor: 2.447

6.  PYK2 integrates growth factor and cytokine receptors signaling and potentiates breast cancer invasion via a positive feedback loop.

Authors:  Michael Selitrennik; Sima Lev
Journal:  Oncotarget       Date:  2015-09-08

7.  The Synthetic β-Nitrostyrene Derivative CYT-Rx20 Inhibits Esophageal Tumor Growth and Metastasis via PI3K/AKT and STAT3 Pathways.

Authors:  Wen-Chin Chiu; Yi-Chen Lee; Yu-Han Su; Yen-Yun Wang; Chun-Hao Tsai; Yi-An Hou; Chie-Hong Wang; Ying-Fong Huang; Chih-Jen Huang; Shah-Hwa Chou; Pei-Wen Hsieh; Shyng-Shiou F Yuan
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

Review 8.  Endosomes as Signaling Platforms for IL-6 Family Cytokine Receptors.

Authors:  Dirk Schmidt-Arras; Stefan Rose-John
Journal:  Front Cell Dev Biol       Date:  2021-06-01

9.  CCL18 from ascites promotes ovarian cancer cell migration through proline-rich tyrosine kinase 2 signaling.

Authors:  Denis Lane; Isabelle Matte; Claude Laplante; Perrine Garde-Granger; Alex Carignan; Paul Bessette; Claudine Rancourt; Alain Piché
Journal:  Mol Cancer       Date:  2016-09-09       Impact factor: 27.401

Review 10.  Spatio-Temporal Parameters of Endosomal Signaling in Cancer: Implications for New Treatment Options.

Authors:  Taras Stasyk; Lukas A Huber
Journal:  J Cell Biochem       Date:  2015-11-16       Impact factor: 4.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.